LBA29 - A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC)
| Autor: | Beltran, H., Danila, D., Montgomery, B., Szmulewitz, R., Vaishampayan, U., Armstrong, A., Stein, M., Hoimes, C., Pinski, J., Scher, H., Puca, L., Bareja, R., Wong, W., Rubin, M., Mosquera, J.M., Sboner, A., Oromendia, C., Nanus, D., Ballman, K., Tagawa, S.T. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi565-vi565 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|